Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fontanet

Showing results (471-480 of 505) with videos related to

Pageof 51
Sort By:
Blood Advances|September 8, 2023
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA studyStephen Opat, Alessandra Tedeschi, Bei Hu, et al.
Plos Neglected Tropical Diseases|August 28, 2020
Human plague: An old scourge that needs new answersXavier Vallès, Nils Chr Stenseth, Christian Demeure, et al.
The New England Journal of Medicine|March 15, 2018
Pregnancy Outcomes after ZIKV Infection in French Territories in the AmericasBruno Hoen, Bruno Schaub, Anna L Funk, et al.
Spanish Journal of Psychiatry and Mental Health|May 2, 2021
PRimary carE digital Support ToOl in mental health (PRESTO): Design, development and study protocolsGerard Anmella, Mireia Primé-Tous, Xavier Segú, et al.
Ebiomedicine|August 5, 2020
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern FranceSamira Fafi-Kremer, Timothée Bruel, Yoann Madec, et al.
Cureus|May 13, 2025
Patterns and Outcomes of Craniomaxillofacial Trauma in Puerto Rico: Insights From a Five-Year Retrospective StudyRaúl Y Ramos-Sánchez, Hermes A Aponte Rivera, Claudia B Sotomayor Rivera, et al.
American Journal of Hematology|June 10, 2018
Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: A series from Lysa centersCédric Rossi, Julia Gilhodes, Marie Maerevoet, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 16, 2021
SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020Arnaud Fontanet, Laura Tondeur, Rebecca Grant, et al.
Ebiomedicine|August 29, 2021
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfectionFloriane Gallais, Pierre Gantner, Timothée Bruel, et al.
British Journal of Haematology|March 3, 2025
A low lymphocyte-to-monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysisPablo Mozas, Romain Ould Ammar, Loïc Chartier, et al.
Pageof 51

Showing results (471-480 of 505) with videos related to

Sort By:
Pageof 51
Blood Advances|September 8, 2023
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA studyStephen Opat, Alessandra Tedeschi, Bei Hu, et al.
Plos Neglected Tropical Diseases|August 28, 2020
Human plague: An old scourge that needs new answersXavier Vallès, Nils Chr Stenseth, Christian Demeure, et al.
The New England Journal of Medicine|March 15, 2018
Pregnancy Outcomes after ZIKV Infection in French Territories in the AmericasBruno Hoen, Bruno Schaub, Anna L Funk, et al.
Spanish Journal of Psychiatry and Mental Health|May 2, 2021
PRimary carE digital Support ToOl in mental health (PRESTO): Design, development and study protocolsGerard Anmella, Mireia Primé-Tous, Xavier Segú, et al.
Ebiomedicine|August 5, 2020
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern FranceSamira Fafi-Kremer, Timothée Bruel, Yoann Madec, et al.
Cureus|May 13, 2025
Patterns and Outcomes of Craniomaxillofacial Trauma in Puerto Rico: Insights From a Five-Year Retrospective StudyRaúl Y Ramos-Sánchez, Hermes A Aponte Rivera, Claudia B Sotomayor Rivera, et al.
American Journal of Hematology|June 10, 2018
Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: A series from Lysa centersCédric Rossi, Julia Gilhodes, Marie Maerevoet, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 16, 2021
SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020Arnaud Fontanet, Laura Tondeur, Rebecca Grant, et al.
Ebiomedicine|August 29, 2021
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfectionFloriane Gallais, Pierre Gantner, Timothée Bruel, et al.
British Journal of Haematology|March 3, 2025
A low lymphocyte-to-monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysisPablo Mozas, Romain Ould Ammar, Loïc Chartier, et al.
Pageof 51